Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Right and Left Ventricular Dysfunction in Critically Ill COVID-19 Patients and the Effects of Inhaled Nitric Oxide: A Sub-study of a Prospective Randomized Controlled Trial

NCT06197256 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT06197256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06197256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Right and Left Ventricular Dysfunction in Critically Ill COVID-19 Patients and the Effects of Inhaled Nitric Oxide: A Sub-study of a Prospective Randomized Controlled Trial
Lead sponsor
Region Stockholm
Phase
Observational
Overall status
Completed
Start date
May 7, 2020
Completion date
February 11, 2021
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, human, cardiac failure, covid-19, left ventricular dysfunction, pulmonary hypertension, right ventricular dysfunction